The Institute of Neurological Sciences in Glasgow is to undergo a £40m modernisation programme to return the building to a 'leading edge' facility.

A series of physically linked developments will make up the project, returning the former hospital building into a leading facility for 21st century medicine and research.

The developments include:

• A new University of Glasgow and NHS Greater Glasgow and Clyde £5m Clinical Research Facility (CRF), on the 5th floor of the neurosciences building.

• A new neuro-physiology department.

• A new Imaging Centre of Excellence (ICE), led by the University of Glasgow and funded as part of the Glasgow and Clyde Valley City Deal, which will include a £7m ultra high-field MRI scanner.

• The creation of new modern operating theatres.

• An external makeover of the neurosciences building to bring it up to the modern style of the Queen Elizabeth University Hospital and the new Royal Hospital for Children.

-- Advertisement --

• New purpose built day treatment unit for patients receiving treatment for ongoing neurological conditions.

• The redesigned and redevelopment of ward 66 to provide facilities incorporating flexible use clinical rooms, pre-assessment, a 19 bedded same-day-admission and day surgery unit and a discharge lounge.

• The introduction of free patient entertainment system and Wi-Fi.

The developments by NHS Greater Glasgow and Clyde (NHSGGC) and the University of Glasgow represent an investment of over £40m between 2013 and 2017.

Health Secretary, Shona Robison, said: "This is a substantial investment that will bring real benefits for patients. It is an exciting project that will update and modernise neuroscience facilities in Glasgow so that they are truly world class and at the cutting edge of the latest technology. It demonstrates our commitment to provide the very best environment and facilities for patients and medical staff across our NHS. That is exactly why we are investing over £12bn in our health service this year for the first time on record, ensuring improvements like these can go ahead."

Robert Calderwood, NHSGGC Chief executive, added: "This tremendous neurosciences modernisation and development programme, in partnership with the University of Glasgow, will give our patents and staff access to the highest quality of theatre, ward, research and imaging facilities. 

"Normally NHS facilities built in the 60s would be getting to the end of their lives by this point but these exciting developments will return this building to a state-of-the-art neurosciences centre once more."

(LM)